Introduction {#sec1}
============

The anaphase-promoting complex/cyclosome (APC/C) is a large cullin-RING E3 ubiquitin ligase responsible for regulating progression through the mitotic phase of the cell cycle and controlling entry into S phase ([@bib4]; [@bib48]; [@bib50]; [@bib57]). The temporal regulation of APC/C-mediated ubiquitin-dependent proteolysis of specific cell cycle proteins is primarily determined by its interactions with two coactivator proteins, the paralogs Cdc20 and Cdh1. Cdc20 activates the APC/C early in mitosis and, through the ubiquitination of securin and mitotic cyclins, promotes the metaphase-to-anaphase transition. Cdh1 associates with the APC/C in late mitosis and during G1.

Coactivators function as adaptors to recruit substrates to the APC/C by their capacity to recognize two conserved APC/C degrons present in most APC/C substrates: the nine-residue D (destruction) box ([@bib23]; [@bib33]) and KEN box ([@bib49]). Coactivators are solely responsible for KEN box recognition ([@bib12]); however, the D box degron is engaged by a bipartite coreceptor on the APC/C-coactivator complex generated from both the coactivator and the core APC/C subunit Apc10 ([@bib10]; [@bib12]; [@bib16]; [@bib27]; [@bib36]). The coactivator's WD40 β-propeller domain interacts with D box and KEN box degrons ([@bib12]; [@bib36]), whereas its N-terminal C box stimulates APC/C catalytic activity ([@bib31]; [@bib37]).

To a large extent, the processes underlying regulation of APC/C activity are exerted through its coactivators. Phosphorylation controls the association of coactivators with the APC/C, and ubiquitination controls Cdc20 abundance ([@bib22]). Cyclin-dependent kinase (CDK)-mediated phosphorylation of Cdh1 blocks APC/C association, and its dephosphorylation in late mitosis promotes formation of an APC/C^Cdh1^ complex. APC/C^Cdh1^ contributes to Cdc20 ubiquitination, augmenting Cdc20 degradation due to its autoubiquitination ([@bib22]). Cdc20 is also regulated by phosphorylation, with dephosphorylation of specific Cdc20 residues being required for C box-dependent APC/C activation ([@bib37]).

Regulation of APC/C activity is intimately associated with inhibition of substrate recognition by Cdc20 and Cdh1 by means of regulatory proteins that incorporate pseudosubstrate inhibitory motifs to interact with degron recognition sites on coactivators. The mitotic checkpoint complex (MCC), a multimer of Cdc20, Mad2, Mad3/BubR1, and Bub3, is the effector of the spindle assembly checkpoint ([@bib30]; [@bib44]). A KEN box motif in Mad3/BubR1 engages the KEN box recognition site of Cdc20, blocking KEN box-dependent substrate recognition ([@bib8]; [@bib12]; [@bib34]; [@bib38]; [@bib54]). In the context of the APC/C^MCC^ complex, D box recognition is prevented through displacement of Cdc20, thereby disrupting formation of the D box coreceptor ([@bib12]; [@bib25]). The vertebrate protein Emi1 inhibits the APC/C through the combination of its conserved D box and a zinc-binding region, which provide strong APC/C-binding affinity to block substrate binding and antagonizing APC/C E3 ligase activity, respectively ([@bib42]).

The concept of inhibiting APC/C-coactivator complexes through a pseudosubstrate mechanism also applies to Acm1 (APC/C Cdh1 modulator 1), an *S. cerevisiae* inhibitor of Cdh1 but not Cdc20 ([@bib20]). Phosphorylated Acm1 functions with the 14-3-3 proteins Bmh1 and Bmh2, forming stable stoichiometric complexes that inhibit APC/C^Cdh1^ by blocking the interaction of Cdh1 with substrates ([@bib18]; [@bib39]). Acm1-Bmh1/Bmh2 complexes contribute to nuclear positioning and spindle morphology by preventing Cdh1 localization to the bud neck, thereby inhibiting Cdh1 from interacting with the protein kinase Hsl1 ([@bib40]). Levels of Acm1 are cell-cycle regulated, with the protein appearing at G1/S and disappearing in late mitosis. Cdc28-dependent phosphorylation of T161 promotes binding of Bmh1 and Bmh2 that contributes to Acm1 stability ([@bib24]; [@bib45]).

A central inhibitory region (CIR) of Acm1 (residues 59--128) incorporating both a KEN box and a D box (DB3) ([Figure 1](#fig1){ref-type="fig"}A) is mainly responsible for the inhibitory properties of Acm1 ([@bib9]; [@bib13]; [@bib20]; [@bib45]). These two motifs mediate interactions of Acm1 with the WD40 domain of Cdh1 ([@bib13]; [@bib39]), indicating that they function as pseudosubstrate motifs, blocking the interaction of substrate with Cdh1. High-affinity Acm1-Cdh1 interactions and optimal APC/C^Cdh1^ inhibition also requires the A motif, a conserved region N-terminal to the KEN motif ([@bib9]; [@bib20]) ([Figure 1](#fig1){ref-type="fig"}A). Acm1 is degraded by APC/C^Cdc20^ during anaphase in a process that requires the N-terminal D box (DB1), which is highly specific for Cdc20 ([@bib20]). Interestingly, Acm1 with disrupted DB3 and KEN boxes becomes a potent substrate of APC/C^Cdh1^ ([@bib9]; [@bib20]; [@bib24]).

Regulatory proteins harboring pseudosubstrate motifs bind coactivators with high affinity; thus, they provide a means by which to investigate the molecular details of degron recognition by coactivators. A crystal structure of *S. pombe* MCC indicated how the KEN motif of Mad3 interacts with and blocks the KEN box recognition site of Cdc20 ([@bib12]). To understand better the mechanisms of D box recognition by coactivators, we have determined the crystal structure of the Cdh1 WD40 domain (Cdh1^WD40^) in complex with the CIR of Acm1 (Acm1^CIR^). From the structure, we reveal details of how coactivator interacts with the majority of the D box residues, rationalizing their conservation. We show that mechanisms of KEN box recognition are likely to be universal, and we rationalize noncanonical KEN and D box degrons. Details of how the Acm1 A motif interacts with Cdh1 provide structural evidence that, in addition to D box and KEN box-binding sites, coactivators utilize additional recognition sites to bind regulatory proteins and (potentially) substrates.

Results and Discussion {#sec2}
======================

Acm1 Contacts Cdh1 through Multiple Motifs {#sec2.1}
------------------------------------------

The CIR of Acm1 (residues 59--128; Acm1^CIR^) ([Figure 1](#fig1){ref-type="fig"}A) was coexpressed with the WD40 domain of Cdh1 (Cdh1^WD40^) in insect cells, and the structure of the complex was determined at 2.9 Å resolution ([Table 1](#tbl1){ref-type="table"}). This revealed an asymmetric heterotetramer comprising two copies of both Acm1^CIR^ and Cdh1^WD40^ ([Figure 1](#fig1){ref-type="fig"}B). Acm1^CIR^ lacks the 14-3-3 recognition site residue pT161 ([@bib24]); thus, isolation of a stable Acm1^CIR^-Cdh1^WD40^ complex without 14-3-3 is consistent with the observation that Acm1--Cdh1 interactions do not require 14-3-3 proteins ([@bib18]; [@bib24]; [@bib39]).

In the Acm1^CIR^-Cdh1^WD40^ heterotetramer, a single Acm1^CIR^ subunit (termed Acm1^CIR^-A) mediates interactions between the two Cdh1^WD40^ molecules (Cdh1^WD40^-A and Cdh1^WD40^-B). The two Cdh1^WD40^ subunits of the heterotetramer are structurally equivalent, and (as expected) the WD40 domain of Cdh1, a seven-bladed β-propeller, shares an identical conformation to its counterpart in Cdc20 ([@bib12]) ([Figure S1](#app3){ref-type="sec"} available online). In contrast, the two Acm1^CIR^ subunits of the complex differ radically. The polypeptide chain of Acm1^CIR^-A is well defined for its entire CIR, whereas the second Acm1 molecule (Acm1^CIR^-B) is only visualized for its N-terminal A motif and adjacent α helix (residues 60--80) ([Figure 1](#fig1){ref-type="fig"}B).

Acm1^CIR^-A contacts the two Cdh1^WD40^ molecules through five segments. Its N-terminal A motif (residues 61--70) engages the lower surface of the Cdh1^WD40^-A toroid, lying in a mainly nonpolar channel between blades 2 and 3 ([Figures 1](#fig1){ref-type="fig"}B, [2](#fig2){ref-type="fig"}A, and 2B). The Acm1^CIR^-A chain then forms an α helix lying parallel to β strand D of blade 3 of Cdh1^WD40^-A ([Figures 1](#fig1){ref-type="fig"}B, [2](#fig2){ref-type="fig"}A, and 2B). Immediately C-terminal to the α helix, Acm1^CIR^-A contacts Cdh1^WD40^-B's KEN box recognition site by means of a highly conserved ^90^NEN sequence ([@bib20]) ([Figures 1](#fig1){ref-type="fig"}B and [3](#fig3){ref-type="fig"}A). E91 and N92 of the Acm1 NEN sequence form interactions to Cdh1 that are equivalent to Mad3 KEN box interactions with Cdc20 ([@bib12]) ([Figures 3](#fig3){ref-type="fig"}A and 3B).

The KEN motif of Acm1^CIR^-A interacts with the Cdh1^WD40^-A KEN box receptor ([Figures 1](#fig1){ref-type="fig"}B and [3](#fig3){ref-type="fig"}C). Similar to the Mad3 KEN box ([@bib12]), the KEN box in Acm1 is incorporated within an underwound helix ([Figures 3](#fig3){ref-type="fig"}C and 3D). P103 of the ^98^KENXX^103^P motif contributes to breaking the KEN motif helix. A CDK phosphorylation site overlaps the C terminus of the ^98^KEN box (^102^SPAK), with P103 corresponding to P+3 of the KENXXP motif ([Figures 1](#fig1){ref-type="fig"}B and [3](#fig3){ref-type="fig"}C). In the crystal structure, electron density showed that S102 is phosphorylated, a modification confirmed by mass spectrometry (data not shown) and consistent with its previous identification in endogenous Acm1 isolated from budding yeast ([@bib24]). By forming a salt bridge with the K105 side chain of the CDK consensus phosphorylation sequence (S/TPXK/R), pS102 stabilizes an incomplete α-helical turn initiated by P103 ([Figures 1](#fig1){ref-type="fig"}B and [3](#fig3){ref-type="fig"}C). Participation of pS102 in stabilizing a short α helix resembles the structure of the CDK phosphorylation site in the retinoblastoma protein ([@bib7]), suggesting a potential common structural consequence of CDK phosphorylation.

D Box Binds to an Interblade Groove on Cdh1 {#sec2.2}
-------------------------------------------

The region of Acm1^CIR^-A incorporating the D box motif (DB3) interacts with Cdh1^WD40^-B at the interface of blades 1 and 7 ([Figures 1](#fig1){ref-type="fig"}B and [4](#fig4){ref-type="fig"}). This site is equivalent to that proposed by [@bib12] as the D box recognition site of Cdc20 in the MCC and, more recently, by ([@bib58]) based on a 2-methyl-2,4-pentandiol (MPD) molecule bound to this site. Seven of the nine consensus D box residues are well defined in the structure, with only the two C-terminal residues not located ([Figures 4](#fig4){ref-type="fig"} and [S2](#app3){ref-type="sec"}). L122 of the D box RXXL motif is anchored in an aliphatic pocket, whereas R119 of the RXXL motif hydrogen bonds with two acidic residues at the top surface of the β-propeller ([Figure 4](#fig4){ref-type="fig"}). To anchor L122 within its binding pocket, the D box motif assumes a tight turn between I120(P2) and K123(P5) (\[P2\] and \[P5\] refer to the second and fifth positions of the D box, respectively) ([Figure 4](#fig4){ref-type="fig"}). The close proximity of these two solvent-exposed residues might exclude bulky amino acids at these positions and explain the predominance of G at P5 of the D box consensus sequence ([@bib23]; [@bib33]) ([Figures 5](#fig5){ref-type="fig"}A and [S3](#app3){ref-type="sec"}A).

The methyl group of A121(P3) of the D box is directed toward the coactivator surface to form a hydrophobic contact with the phenyl ring of F286 of Cdh1 ([Figure 4](#fig4){ref-type="fig"}). F or Y at this position is conserved in all Cdc20 and Cdh1 homologs ([@bib12]), perhaps explaining the preference for the nonbulky A, P, and S amino acids at this D box position ([Figures 5](#fig5){ref-type="fig"}A and [S3](#app3){ref-type="sec"}A). The carboxylate of D124(P6) forms a long hydrogen bond to R253 of Cdh1, rationalizing why D and E are the two most common residues at P6 of the D box ([Figures 5](#fig5){ref-type="fig"}A and [S3](#app3){ref-type="sec"}A). Finally, the aliphatic side chain of L125(P7) interacts with a conserved nonpolar patch on Cdh1, explaining the propensity of V, I, and L at this D box position ([Figures 5](#fig5){ref-type="fig"}A and [S3](#app3){ref-type="sec"}A). Interestingly, K is the fifth most frequent residue at P7, and modeling shows that its aliphatic moiety would contact the nonpolar surface, whereas its charged amino group would be positioned to contact the acidic cluster of the R(P1)-binding site. Residues P8 and P9 of the Acm1 D box (S and V, respectively) are disordered. S is a preferred residue at P8, whereas N is preferred and V is rare at P9 ([@bib23]; [@bib33]) ([Figures 5](#fig5){ref-type="fig"}A and [S3](#app3){ref-type="sec"}A). Thus, the disorder at the C terminus of the D box could result from a nonconsensus residue at P9. Alternatively, the D box coreceptor Apc10 may contribute to the ordering of the D box C terminus.

Disrupting either the L-binding pocket or the R-binding site abrogated the ability of APC/C^Cdh1^ to ubiquitinate securin (a D box-dependent substrate) ([@bib12]), consistent with this model for D box recognition. A cluster of four residues of human Cdh1 was previously implicated in D box recognition ([@bib36]). Our structure rationalizes two of these residues: L255 (*S. cerevisiae* numbering) contacts the side chain of the D box L residue, whereas P258 contacts the aliphatic moiety of the D box R ([Figure 4](#fig4){ref-type="fig"}A).

The A Motif Contributes to Specificity for Cdh1 {#sec2.3}
-----------------------------------------------

Due to the asymmetric heterotetramer, only the A motif and adjacent α helix (residues 61--80) of Acm1^CIR^-B bind Cdh1^WD40^-B ([Figure 1](#fig1){ref-type="fig"}B). This indicates that the A motif and its immediate flanking regions are sufficient to mediate Acm1-Cdh1 association. Acm1^CIR^ was previously shown to bind Cdh1 independently of the KEN box and DB3 ([@bib9]). E65 and E66 of the A motif contribute to Acm1^CIR^ interactions with Cdh1 (residues 1--128) ([@bib9]), in agreement with findings that residues 59--69 of Acm1 are required for high-affinity Cdh1 binding ([@bib20]). The interaction of the A motif with a noncanonical binding site on Cdh1, suggesting the possibility that the A motif could contribute as an APC/C^Cdh1^ degron, is supported by a study showing that APC/C^Cdh1^-mediated ubiquitination of Acm1 (residues 1--128) with mutated DB3 and KEN box motifs, but retaining DB1, is abolished by disrupting the A motif ([Figure 4](#fig4){ref-type="fig"}B by [@bib9]).

To explain why Acm1 is not a Cdc20 inhibitor ([@bib20]), we analyzed Acm1 contacts to residues specific to Cdh1. We focused on the A motif-binding site of Cdh1, which is less well conserved than the D box- and KEN box-binding sites ([Figure 2](#fig2){ref-type="fig"}C). Interactions at this site include a salt bridge linking E65 of Acm1 with K333 of Cdh1 and hydrophobic contacts between F61 and Y64 of Acm1 with I311 and P374 of Cdh1, respectively ([Figure 2](#fig2){ref-type="fig"}D). To test the roles of I311 and K333 in conferring Acm1-specific inhibition of Cdh1, we mutated these residues to their counterparts in Cdc20. Although the resulting mutant (Cdh1^I311S,K333T^) was still able to activate the APC/C to ubiquitinate securin, this activity was now only poorly inhibited by Acm1 ([Figure 2](#fig2){ref-type="fig"}E). A second Cdh1 mutant, incorporating additional mutations of Acm1-contacting residues of Cdh1 to their counterparts in Cdc20 (L325N, I344G, and P374K), although still active, was even less sensitive to Acm1-mediated inhibition ([Figures 2](#fig2){ref-type="fig"}D and 2E).

These data indicate that the Acm1 A motif contributes to determining Acm1-specificity for Cdh1. However, it is also possible that other regions of Acm1, such as the K box, may also contribute to its specificity for Cdh1 ([Figure 1](#fig1){ref-type="fig"}A) ([@bib9]).

Acm1^CIR^-Cdh1 Heterodimers Mediate APC/C Inhibition {#sec2.4}
----------------------------------------------------

To understand the biological relevance of the Acm1^CIR^-Cdh1^WD40^ heterotetramer, we determined the size of Acm1-Cdh1^WD40^ complexes in solution. Acm1^CIR^-Cdh1^WD40^ at ∼1 mg/ml exists as a mixture of heterotetrameric and heterodimeric species as assessed by multiangle light scattering (MALS) ([Figures S4](#app3){ref-type="sec"}A and S4B). Glycerol promotes the conversion of heterodimers into heterotetramers, as shown by size-exclusion chromatography ([Figure 6](#fig6){ref-type="fig"}A) and MALS ([Figures S4](#app3){ref-type="sec"}C and S4D). However, similar MALS analysis of a longer fragment of Acm1 (residues 59--209; Acm1^ΔN^) with a disrupted 14-3-3-binding site (Acm1^ΔN-T161A^-Cdh1^WD40^) indicated only a heterodimeric species in glycerol buffer ([Figures S4](#app3){ref-type="sec"}E and S4F). When we coexpressed wild-type (WT) Acm1^ΔN^ with Cdh1^WD40^ in insect cells, we isolated a complex bound to insect cell 14-3-3 proteins ([Figure S4](#app3){ref-type="sec"}G). The mass of this complex, determined using analytical ultracentrifugation (AUC) at 1.5 mg/ml, is consistent with two Acm1^ΔN^-Cdh1^WD40^ heterodimers bound to a 14-3-3 dimer ([Figure S4](#app3){ref-type="sec"}H). To further investigate the structure of Acm1-Cdh1^WD40^ complexes in solution, we performed small-angle X-ray scattering (SAXS) on Acm1^CIR^-Cdh1^WD40^ at a concentration of \>10 mg/ml. The experimental SAXS profile closely matches the computed SAXS profile for the Acm1^CIR^-Cdh1^WD40^ tetramer ([Figure 6](#fig6){ref-type="fig"}B).

To test whether Cdh1-Acm1^CIR^ dimers are sufficient to mediate APC/C^Cdh1^ inhibition, we mutated the NEN sequence of Acm1^CIR^ (Acm1^CIR-mNEN^), promoting heterodimers as judged by SAXS and size-exclusion chromatography ([Figures 6](#fig6){ref-type="fig"}A, 6C, and [S4](#app3){ref-type="sec"}I). The experimental SAXS profile of Acm1^CIR-mNEN^ matches closely to the computed SAXS profile for the modeled Acm1^CIR^-Cdh1^WD40^ dimer ([Figure 1](#fig1){ref-type="fig"}C). Acm1^CIR-mNEN^ is as effective as WT Acm1^CIR^ at inhibiting APC/C^Cdh1^ ([Figure 6](#fig6){ref-type="fig"}D), whereas Acm1^CIR-mdb3^ (Acm1^CIR^ with a disrupted DB3), which also destabilizes heterotetramers in favor of heterodimers similar to Acm1^CIR-mNEN^ ([Figure 6](#fig6){ref-type="fig"}A), is defective as an Acm1 inhibitor ([Figures 6](#fig6){ref-type="fig"}D and [S4](#app3){ref-type="sec"}J). Thus, Acm1^CIR^-Cdh1^WD40^ heterotetramers are not relevant to Acm1-mediated inhibition of Cdh1. Together, these data indicate that the biologically relevant form of Acm1-Cdh1 is most likely the heterodimer and that the heterotetrameric assembly of Acm1^CIR^-Cdh1^WD40^, as observed in the crystal structure, is promoted by high unphysiological protein concentrations and the absence of the Acm1's C-terminal 81 residues, possibly due to loss of the K motif in Acm1^CIR^ ([Figure 1](#fig1){ref-type="fig"}A) ([@bib9]).

Some APC/C Degrons Are Degenerate D and KEN Boxes {#sec2.5}
-------------------------------------------------

These structural data provide a basis for understanding how coactivators recognize D box and KEN box degrons and thus a rationale for D box and KEN box consensus residues. We generated revised D box and KEN box consensus sequences by aligning 68 D box and 46 KEN box motifs, previously published and validated by mutagenesis ([Figures 5](#fig5){ref-type="fig"}A, 5B, and [S3](#app3){ref-type="sec"}). This identifies a consensus sequence flanking the KEN residues ([Figure 5](#fig5){ref-type="fig"}B) with D and N, the most frequent residues, immediately preceding the KEN residues (position P−1). Model building indicates that either residue could promote and stabilize the KEN box conformation through a side-chain-hydrogen bond to N of the KEN motif ([Figure 5](#fig5){ref-type="fig"}E). A consensus P at P+3 and (at lower conservation) at P+2 ([Figure 5](#fig5){ref-type="fig"}B) breaks the α helix incorporating the KEN box and directs the polypeptide chain away from the coactivator surface. The similar helical conformations of the KEN box motifs and immediate flanking residues of both Mad3 and Acm1 bound to Cdc20 and Cdh1, respectively ([Figure 3](#fig3){ref-type="fig"}D), would suggest that most, if not all, KEN boxes bind coactivators through a similar mechanism.

Our revised D box and KEN box consensus motifs, combined with a structural rationale for conserved residues, prompted us to examine whether nonconsensus APC/C degrons may represent noncanonical D box and KEN box motifs. We note that the consensus D box features a P at P−1 and an N at P+1, thereby extending the D box motif to eleven residues ([Figure 5](#fig5){ref-type="fig"}A). The O box identified as an APC/C degron in Orc1 closely matches the D box consensus, except that R(P1) is replaced by A ([Figure 5](#fig5){ref-type="fig"}C) ([@bib2]). The O box potentially may bind the D box receptor, consistent with the ability of a D box peptide to interfere with O box recognition by APC/C^Cdh1^ ([@bib2]). Sullivan and Morgan described a novel degron in *S. cerevisiae* Spo13, a protein that lacks identifiable D and KEN box motifs ([@bib55]). However, similar to the O box, the Spo13 motif conforms quite closely to a D box, deviating due to a Q at P1 and a P at P9 ([Figure 5](#fig5){ref-type="fig"}C). Both the O box and the Spo13 degron incorporate a K at P7 that could substitute for the canonical R at P1 and interact with acidic residues at the D box R-binding site. Finally, degradation of the spindle motor protein Cin8p depends on a bipartite destruction sequence that comprises a KEN box 22 residues N-terminal to a C-terminal degron that resembles a degenerate D box comprising a conserved and essential L residue ([Figure 5](#fig5){ref-type="fig"}C). Cin8p lacks functional canonical D box motifs ([@bib26]).

A D box peptide (modeled on Hsl1) inhibits APC/C^Cdh1^-catalyzed ubiquitination of securin, and the same peptide, but not a control peptide, also inhibits ubiquitination of Spo13 and Cin8p ([Figure 7](#fig7){ref-type="fig"}A). These results indicate that APC/C^Cdh1^ recognizes all three substrates through its D box coreceptor. To determine whether the Spo13 degron, C-terminal Cin8p degron, and O box are degenerate D boxes, we tested whether peptides incorporating these degrons blocked the ability of APC/C^Cdh1^ to ubiquitinate Clb2. In this assay, we used a KEN box mutant of Clb2 (Clb2^mkb^) whose ubiquitination is dependent on its recognition by the D box coreceptor. [Figure 7](#fig7){ref-type="fig"}B shows that a D box peptide (modeled on Hsl1), but not a control peptide, abrogates Clb2^mkb^ ubiquitination by APC/C^Cdh1^ to a level similar to that of Clb2 with both its D and KEN boxes disrupted (Clb2^mdk^) (compare lanes 6, 9, 10, and 14). The Cin8p degron peptide strongly reduces Clb2^mkb^ ubiquitination (lane 13), whereas the O box and Spo13 degron peptides less-effectively inhibit Clb2^mkb^ ubiquitination (lanes 11 and 12). These data show that the Cin8p degron is a noncanonical D box degron; interestingly, this degron features a K at P1 of the D box motif. The less-efficient inhibition of Clb2^mkb^ ubiquitination by the O box and Spo13 degron peptides indicates that the O box and Spo13 degron possess a weaker affinity for the D box receptor. These data showing that the Cin8p, O box, and Spo13 degrons interact with the D box receptor, together with the observation that a histidine substitutes for R(P1) in the D box of human shugoshin 1 (Sgo1) ([@bib29]) ([Figure 5](#fig5){ref-type="fig"}C), demonstrate that residues other than R can be accommodated at the P1 position of the D box receptor.

The Acm1^CIR^-Cdh1^WD40^ structure shows that the KEN box receptor of Cdh1^WD40^-B binds a NEN sequence of Acm1, suggesting the possibility that degenerate KEN motifs are recognized as APC/C degrons. Previously, [@bib11] identified the GxENxP degron in Xkid, which otherwise lacks a canonical KEN box motif. Since the EN and P residues match the consensus KEN motif ([Figures 5](#fig5){ref-type="fig"}B and 5D), we considered it possible that the GxENxP motif might bind to the KEN box receptor of the coactivator. In an in vitro ubiquitination assay, we found that glutathione S-transferase (GST) fused to a fragment of Xkid (residues 498--600 incorporating GxENxP) ([@bib11]) was efficiently ubiquitinated by WT Cdh1 but not Cdh1 with a disrupted KEN box receptor ([Figure 7](#fig7){ref-type="fig"}C). These data indicate that the GxENxP degron present within residues 498--600 of Xkid requires the KEN box receptor of Cdh1. [Figure 7](#fig7){ref-type="fig"}A shows that ubiquitination of the Xkid fragment is also blocked by a D box peptide, in agreement with the findings of [@bib11] and our data in [Figure 7](#fig7){ref-type="fig"}C showing that Cdh1 with a mutant D box receptor ubiquitinates Xkid poorly. Thus, we conclude that efficient Xkid ubiquitination is dependent on both the D and KEN box-binding sites of coactivator.

Conclusions {#sec2.6}
-----------

Our structural analysis of the Acm1^CIR^-Cdh1^WD40^ complex reveals the molecular basis for D box recognition by coactivator and demonstrates a mode of KEN box recognition by Cdh1 that is common to Cdc20. We rationalize D box and KEN box consensus sequences and show that noncanonical D box and KEN box motifs are recognized at the D box and KEN box receptors, respectively. The interaction of the Acm1 A motif with Cdh1 reveals a third protein-binding site on Cdh1, a site poorly conserved with Cdc20, and therefore likely to confer coactivator-specific functions. Acm1 inhibits Cdh1 as a heterodimer by sterically blocking D and KEN box recognition. This is similar to how the MCC inhibits KEN box recognition by Cdc20 but differs from the mechanism of D box coreceptor disruption by the MCC ([@bib12]). Since the fission yeast meiotic APC/C^Cdc20^ inhibitor Mes1 has an arrangement of pseudosubstrate KEN and D boxes similar to that of Acm1 ([@bib32]), it is likely to exert its effects through a similar mechanism. Furthermore, a meiotic inhibitor of the APC/C in plants, OSD1, containing GxEN and D box motifs separated by 20 residues is also likely to function as a pseudosubstrate inhibitor ([@bib15]), whereas Emi1 combines both D box-binding and E3 ligase inhibitory mechanisms ([@bib42]).

Experimental Procedures {#sec3}
=======================

Preparation of Insect Cell and IVT Expression Vectors {#sec3.1}
-----------------------------------------------------

### Constructs for Insect Cell Expression {#sec3.1.1}

The *Saccharomyces cerevisiae* Cdh1 WD40 domain (residues 241--550) and Acm1 CIR (residues 59--128) were amplified by PCR and cloned into a modified pFBDM vector ([@bib5]) (Z.Z. and D.B., unpublished data). A double Strep-tag II and a tobacco etch virus (TEV) cleavage site were introduced N-terminal of Cdh1 for affinity purification. A similar approach was used for coexpression of the Cdh1^WD40^-Acm1 mutants (Acm1^CIR-mNEN^: Acm1^CIR\ -N90A/E91A/N92A^; Acm1^CIR-mdb3^: Acm1^CIR-R119S/L122A^-DB3 mutant; Acm1^ΔN^: Acm1^(59--209)^; Acm1^ΔN-T161A^: Acm1^(59--209)-T161A^). Mutagenesis was performed using uracil-specific excision reagent (USER)-based mutagenesis ([@bib6]).

### Constructs for IVT-Based Ubiquitination Assays {#sec3.1.2}

The *S. cerevisiae* Cdh1 mutants (*Sc*Cdh1^I311S/K333T^ and *Sc*Cdh1^I311S/K333T/L325N/L344G/P374K^), WT Acm1^CIR^, and mutants (Acm1^CIR-mNEN^ and Acm1^CIR-mdb3^) were cloned into a pRSET vector. The noncanonical degron substrate *S. cerevisiae* Spo13 was cloned into pRSET, whereas *Xenopus laevis* Xkid (residues 498--600) and *S. cerevisiae* Cin8p (residues 956--1031) were cloned into pRSET with an N-terminal GST tag followed by three K residues. *H. sapiens* Cdh1 and securin were cloned into pRSET vectors. The KEN box receptor mutants (Q401A and R445L) and D box receptor mutant (V203M) of *Hs*Cdh1 (equivalent to Q473A, R517L, and V279M of *Sc*Cdh1, respectively; described in [@bib12]) were generated using USER-based mutagenesis ([@bib6]). pRSET vectors for WT *S. cerevisiae* Cdh1, securin, WT Clb2, and mutant Clb2 (KEN box and combined D box and KEN box) were described by [@bib46].

Protein Expression in Insect Cells and Purification {#sec3.2}
---------------------------------------------------

The pFBDM-based construct of the Acm1^CIR^-Cdh1^WD40^ complex was used to generate baculovirus that was then amplified to a suitable titer (\>1 × 10^8^ plaque-forming units \[pfu\]/ml). *Sf*9 cells were grown in Sf-900 II SFM medium (Invitrogen) to a cell density of 2.0 × 10^6^ cells/ml and infected at an moi of 2. The *Sf*9 cells were harvested after 72 hr, and the cell pellets were frozen at −80°C. To purify the complex, the cell pellets were resuspended and lysed in lysis buffer (50 mM Tris-HCl \[pH 8\], 300 mM NaCl, 0.4 g/ml DNase, one Protease Inhibitor Cocktail Tablet per 50 ml lysate, 2 mM dithiothreitol (DTT), and 0.5 mM EDTA). The lysate was clarified by centrifugation and subsequently applied to a Strep-Tactin affinity chromatography column (QIAGEN). The bound protein was washed with wash buffer (25 mM Tris-HCl \[pH 8\], 250 mM NaCl, 2 mM DTT, and 0.5 mM EDTA) and eluted with 2.5 mM desthiobiotin. The N-terminal tag was cleaved using 0.1 mg/ml TEV protease overnight. The complex was further purified by anion-exchange chromatography (RESOURCE Q, GE Healthcare) followed by size-exclusive chromatography (Superdex 75, GE Healthcare) in 10 mM Tris-HCl (pH 8.0), 150 mM NaCl, 2 mM DTT, 0.5 mM EDTA, and 10% (v/v) glycerol. The identities of the purified complex subunits were confirmed by mass spectrometry. Acm1^CIR-mNEN^-Cdh1^WD40^, Acm1^CIR-mdb3^-Cdh1^WD40^, and Acm1^ΔN-T161A^-Cdh1^WD40^ were prepared using the same procedure, except that a Superdex 200 column was used for Acm1^ΔN-T161A^-Cdh1^WD40^.

Recombinant *S. cerevisiae* APC/C and recombinant *H. sapiens* APC/C were prepared as described in [@bib52] and [@bib59], respectively.

Crystallization of the Acm1^CIR^- Cdh1^WD40^ Complex {#sec3.3}
----------------------------------------------------

Purified Acm1^CIR^-Cdh1^WD40^ complex was concentrated to 14 mg/ml and crystallized by sitting-drop vapor diffusion at 4°C in 0.1 M Na cacodylate (pH 6.0), 40% (v/v) MPD, and 3% (w/v) polyethylene glycol (PEG) 8000. Crystals were directly mounted into cryoloops from drops and flash frozen at 100 K for data collection.

Data Collection and Structure Determination {#sec3.4}
-------------------------------------------

A native data set was collected to 2.9 Å on beamline I04-1 (Diamond Light Source), processed using X-ray detector software (XDS) ([@bib28]), and scaled with Scala ([@bib21]). Molecular replacement was performed with Phaser ([@bib41]) using *S. pombe* Cdc20/Slp1 (Protein Data Bank ID code [4AEZ](pdb:4AEZ){#intref0010}; [@bib12]) as a search model. Iterative cycles of manual model building and refinement were performed with Coot ([@bib19]) and Refmac ([@bib43]), respectively. Translation libration screw-motion (TLS) refinement in PHENIX ([@bib1]) was also introduced. The structure was validated with MolProbity ([@bib17]). Data collection and refinement statistics are listed in [Table 1](#tbl1){ref-type="table"}. Coordinates were analyzed using COOT ([@bib19]), Superpose ([@bib14]) and PyMol. For analysis and figures, the Acm1^CIR^-Cdh1^WD40^ heterotetramer composed of Acm1-A chain I, Acm1-B chain N, Cdh1-A chain A, Cdh1-B chain E was used ([Figure S1](#app3){ref-type="sec"}).

Modeling the Acm1^CIR^-Cdh1^WD40^ Dimer {#sec3.5}
---------------------------------------

DB3 of Acm1^CIR^-A-Cdh1^WD40^-B was superimposed onto Acm1^CIR^-A-Cdh1^WD40^-A. The 13 residue linker connecting P103 of the KEN box to R119 of DB3 was modeled using COOT ([@bib19]).

SAXS Data Collection and Data Analysis {#sec3.6}
--------------------------------------

Acm1^CIR^-Cdh1^WD40^ and Acm1^CIR-mNEN^-Cdh1^WD40^ complexes were concentrated to approximately 26 mg/ml. SAXS data were collected at the SWING beamline (Synchrotron SOLEIL). The beam size was 400 × 100 μm, the beam energy was 12.4 keV, and the flux was approximately 10^12^ photons/s. The images were collected using the AVIEV170170 charge-coupled device (CCD) detector, and the SAXS cell to detector distance was 1,892 cm. The samples were loaded in gel filtration buffer using an online high-performance liquid chromatography (HPLC) device and a Shodex KW402.5-4F size-exclusion column. The column and flow cell were maintained at 10°C and the sample holder prior to injection at 4°C. Data were processed using the beamline software FOXTROT, and Guinier analysis was performed using PRIMUS ([@bib35]). To determine the oligomeric assembly of the Acm1^CIR^-Cdh1^WD40^ complex in solution, theoretical SAXS profiles for the heterodimeric and heterotetrameric models of the Acm1^CIR^-Cdh1^WD40^ complex were calculated and fitted to the SAXS experimental profiles with the FoXS web server ([@bib51]). Radii of gyration (R~g~) were determined from the experimental SAXS profile using GNOM ([@bib56]), and R~g~ was calculated using FoXS.

Preparation of the Acm1^ΔN^-Cdh1^WD40^-14-3-3 Complex for AUC {#sec3.7}
-------------------------------------------------------------

Acm1^ΔN^ (residues 59--209) and Cdh1^WD40^ were coexpressed in insect cells, and the complex was purified as for Cdh1^WD40^-Acm1^CIR^ but without DTT. The complex was exchanged into AUC buffer (gel filtration buffer without DTT) through size-exclusion chromatography (Superdex 200, GE Healthcare). Eluted fractions were concentrated to 7.5 mg/ml, and flash frozen in liquid nitrogen. AUC runs were performed at a protein concentration of 1.5 mg/ml on a Beckman Coulter XL-I Analytical Ultracentrifuge with interference optics. The run speed was 40,000 rpm at 20°C. We performed 53 scans at 12 min intervals. Sedimentation coefficients and c(M) were determined using the c(s) model within SEDFIT ([@bib53]).

Multiple Angle Light Scattering {#sec3.8}
-------------------------------

Purified Acm1^CIR^-Cdh1^WD40^ was applied at a concentration of 10 mg/ml to a Superdex 75 analytical gel filtration column (24 ml; GE Healthcare) at a flow rate of 0.5 ml/min in 10 mM Tris-HCl (pH 8.0), 150 mM NaCl, 0.5 mM EDTA, 2 mM DTT, 0.02% (w/v) NaN~3~ either with or without 10% (v/v) glycerol. Acm1^ΔN-T161A^-Cdh1^WD40^ was applied at a concentration of 7 mg/ml to a Superdex 200 analytical gel filtration column (24 ml; GE Healthcare) at a flow rate of 0.5 ml/min in the same buffer with 10% (v/v) glycerol. MALS data were measured at 20°C on the eluate at 658 nm using a DAWN HELEOS light scattering instrument (Eldan) and processed using ASTRA software.

Size-Exclusion Chromatography {#sec3.9}
-----------------------------

Acm1^CIR^-Cdh1^WD40^, Acm1^CIR-mNEN^-Cdh1^WD40^, and Acm1^CIR-mdb3^-Cdh1^WD40^ complexes were loaded at ∼5 mg/ml onto a HiLoad Superdex 75 column in gel filtration buffer at 4°C (except where stated for WT Acm1^CIR^-Cdh1^WD40^).

APC/C Ubiquitination Assays {#sec3.10}
---------------------------

APC/C ubiquitination assays with *S. cerevisiae* APC/C and *S. cerevisiae* Cdh1 were adopted and modified from ([@bib47]) (data in [Figures 2](#fig2){ref-type="fig"}E, [6](#fig6){ref-type="fig"}D, [7](#fig7){ref-type="fig"}A, and 7B). ^35^S-labeled substrates (*S. cerevisiae* securin \[Pds1p\], Clb2p \[WT, KEN, and D box mutants; described by [@bib47]\], *S. cerevisiae* Spo13, GST-Cin8p, and *X. laevis* GST-Xkid) and unlabeled *S. cerevisiae* WT Cdh1 and mutants (as described above) were prepared in vitro using the TNT T7 Quick Coupled Transcription/Translation System (Promega). Each ubiquitination reaction contains approximately 10 ng of recombinant *S. cerevisiae* APC/C, 1 μl of ^35^S-labeled substrate, and 2 μl of Cdh1 in a 10 μl reaction volume with 40 mM Tris-HCl (pH 7.5), 10 mM MgCl~2~, 0.6 mM DTT, 2.7 mM ATP, 6.6 μg methyl-ubiquitin, 200 ng UBE1, 500 ng *S. cerevisiae* Ubc4, 200 ng ubiquitin aldehyde (Enzo), and 2 mM LLnL (N-Acetyl-Leu-Leu-Norleu-aldehyde) (Sigma). Reactions were incubated at 22°C for 60 min and analyzed by 10% SDS-PAGE. Gels were fixed and stained with Coomassie blue followed by drying and exposure to BioMax MR Film (Kodak).

APC/C ubiquitination assays with *H. sapiens* APC/C and *H. sapiens* Cdh1 were performed using a procedure similar to that for *S. cerevisiae* APC/C and Cdh1 ([@bib47]) as described above, except 500 ng UbcH10 was used instead of Ubc4 (data in [Figure 7](#fig7){ref-type="fig"}C). ^35^S-labeled substrates (*X. laevis* GST-Xkid and *H. sapiens* securin) and unlabeled *H. sapiens* Cdh1 and its mutants were prepared in vitro as described above.

APC/C Inhibition Assays {#sec3.11}
-----------------------

### Acm1-Mediated Inhibition with ScAPC/C and ScCdh1 {#sec3.11.1}

For the Acm1-mediated APC/C inhibition assays, unlabeled WT Acm1^CIR^ and its mutants were prepared in vitro as described above. Acm1^CIR^ was preincubated with in vitro translated (IVT)-generated *Sc*Cdh1 or its mutants (1 μl of Cdh1 and 2 μl of Acm1) for 10 min before addition to the reaction mix (10 μl reaction volume). The ubiquitination reactions and analyses were performed as described above.

### Peptide-Mediated Inhibition with ScAPC/C and ScCdh1 {#sec3.11.2}

The following peptides were synthesized by Cambridge Peptides and dissolved in Tris-HCl (pH 7.0) at 10 mM: D box peptide (Hsl1, residues 827--837): Ac-SKRAALSDITNSSD-NH~2~; O box peptide: Ac-SPASPLTEKNAKSD-NH~2~; Spo13 peptide: Ac-SVQKPLQEKTPNSD-NH~2~; Cin8p peptide: Ac-SKKMPLRLSNINSD-NH~2~; control peptide: Ac-SDSAKSADSASASD-NH~2~. These peptides correspond to the putative noncanonical D box degrons as defined in [Figure 5](#fig5){ref-type="fig"}C (i.e., an eleven residue motif: −1 to +1), flanked by N- and C-terminal serines.

For the peptide-mediated inhibition assays, the ubiquitination reaction was performed as described above, except that peptides were preincubated with *Sc*Cdh1 for 10 min at a final concentration of 1 mM.

Accession Numbers {#app1}
=================

Protein coordinates have been deposited in the Protein Data Bank under ID code [4BH6](pdb:4BH6){#intref0015}.

Structure factors have been deposited in the Protein Data Bank under ID code [R4BH6SF](pdb:R4BH6SF){#intref0020}.
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========================
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![Structure of Acm1^CIR^-Cdh1^WD40^\
(A) Schematic of *S. cerevisiae* Acm1. A, A motif; DB1, N-terminal D box; NEN, ^90^N-^91^E-^92^N; KEN and DB3, pseudosubstrate KEN and D box (DB3) inhibitory motifs; SP, S102 CDK2 phosphorylation site; P, pT161-14-3-3 binding site; K, K motif.\
(B) Acm1^CIR^-Cdh1^WD40^ heterotetramer. F113 of Acm1^CIR^-A was not located in the electron density maps and is represented with a dashed line.\
(C) Model for the Acm1^CIR^-Cdh1^WD40^ heterodimer. A 13 residue linker was modeled between P103 (KEN) and R119 (DB3) (separated by 15 residues), indicating that it is stereochemically possible for the KEN box and DB3 motif of Acm1 to interact with their respective sites on the same Cdh1 molecule. K123 of the DB3 was omitted for clarity. See also [Figure S1](#app3){ref-type="sec"}.](gr1){#fig1}

![The A Motif-Binding Site\
(A) Details of A motif-Cdh1^WD40^ interactions at the interblade groove.\
(B) Surface rendition of Cdh1^WD40^ at the A motif-binding site.\
(C) The modeled Acm1^CIR^-Cdh1^WD40^ heterodimer with the Cdh1^WD40^ surface representation colored according to the sequence conservation of Cdc20 and Cdh1. The A motif lies in an interblade channel, which is less well conserved than the D box- and KEN box-binding sites.\
(D) Comparison of Cdh1^WD40^ (green) and Cdc20^WD40^ (purple) at the A motif-binding site shows why Cdc20 is not inhibited by Acm1. The five residues of Cdh1 that contact the A motif and differ from Cdc20 (I311, L325, K333, I344, and P374) are shown.\
(E) Residues of Cdh1 that differ from Cdc20 (shown in C) were replaced with the Cdc20 equivalents, and WT and mutant Cdh1 proteins were tested for their sensitivity to Acm1-mediated inhibition. In vitro APC ubiquitination assays show that the mutant incorporating two key residues (Cdh1^I331S/K333T^) was poorly inhibited by Acm1 and a mutant incorporating all five residues (Cdh1^I331S/K333T/L325N/I344G/P374K^) was even less sensitive to Acm1-mediated inhibition.](gr2){#fig2}

![The KEN Motif and NEN Sequence Bind to the Conserved KEN Box Site of Coactivators\
(A) Details of NEN sequence-Cdh1 interactions.\
(B) Comparison of the NEN sequence of Acm1^CIR^-B bound to Cdh1^WD40^-B and the KEN motif of *S. pombe* Mad3 bound to *S. pombe* Cdc20^WD40^.\
(C) Details of KEN box and CDK phosphorylation site (pS102)-Cdh1 interactions.\
(D) Comparison of the KEN motif of Acm1^CIR^-A bound to Cdh1^WD40^-A and the KEN motif of *S. pombe* Mad3 bound to *S. pombe* Cdc20^WD40^.](gr3){#fig3}

![D Box Binds to an Interblade Groove in Cdh1\
(A) Details of DB3 box-Cdh1 interactions showing the N-terminal seven residues of D box.\
(B) Surface rendition of Cdh1 at the D box-binding site. See also [Figure S2](#app3){ref-type="sec"}.](gr4){#fig4}

![Consensus D Box and KEN Box Motifs and Related Noncanonical APC/C Degrons\
(A) Sequence motif of D box derived from 68 APC/C substrates. Sequence motif determined using multiple expectation maximization for motif elicitation (MEME) ([@bib3]). The D box sequences used are listed in [Figure S3](#app3){ref-type="sec"}A.\
(B) Sequence motif of KEN box derived from 46 APC/C substrates. KEN box sequences are listed in [Figure S3](#app3){ref-type="sec"}B.\
(C) Comparison of consensus D box with O box degron ([@bib2]), the *S. cerevisiae* Spo13 degron ([@bib55]), the *S. cerevisiae* Cin8p degron ([@bib26]), the D box of human Sgo1 ([@bib29]), and DB3 of Acm1. Underlined residues are essential for APC/C-mediated degradation. Red: D box consensus R and L residues; blue: D box consensus residues; orange: consensus P−1 and P+1 residues.\
(D) Comparison of consensus KEN box with the GxEN degron of Xkid ([@bib11]). Red: invariant residues; blue: conserved residues.\
(E) Structural rationale for conservation of D or N at P−1 of KEN motif. Side chain of D or N stabilizes the KEN box conformation through a hydrogen bond with the amide side chain of the KEN box N residue. Modeled on the KEN box of Mad3 ([@bib12]).](gr5){#fig5}

![Oligomeric States of Acm1-Cdh1^WD40^\
(A) Size-exclusion chromatography of WT Acm1^CIR^-Cdh1^WD40^ without glycerol shows heterotetramers (peak 1) and heterodimers (peak 2). Glycerol (10% v/v) promotes heterotetramers. Associated SDS-PAGE gels are shown in [Figures S4](#app3){ref-type="sec"}B and S4D. Only heterodimers are observed when either the NEN sequence (Acm1^CIR-mNEN^-Cdh1^WD40^) or DB3 is disrupted (Acm1^CIR-mdb3^-Cdh1^WD40^). The latter two samples were run with 10% (v/v) glycerol. Associated SDS-PAGE gels shown in [Figures S4](#app3){ref-type="sec"}I and S4J.\
(B and C) SAXS profiles for Acm1^CIR^-Cdh1^WD40^ and Acm1^CIR-mNEN^-Cdh1^WD40^ complexes. (B) Experimental SAXS profile (black dots) for Acm1^CIR^-Cdh1^WD40^ compared with computed SAXS profiles for the Acm1^CIR^-Cdh1^WD40^ tetramer (cyan) and dimer (red). It shows a good fit to the computed SAXS profile of the tetramer (χ^2^ = 12) but is a poor match to the computed SAXS profile of the dimer (χ^2^ = 93). The experimental radius of gyration (R~g~) for Acm1^CIR^-Cdh1^WD40^ is 31 Å, and the calculated radii of gyration for tetramer and dimer models are 28 Å and 20 Å, respectively. The scattering vector q = 4πsin(θ)/λ, where θ is half the scattering angle. (C) Experimental SAXS profile (black dots) of Acm1^CIR-mNEN^-Cdh1^WD40^ shows a good fit to the computed SAXS profile of the dimer (χ^2^ = 3.7) but is a poor match to the computed SAXS profile of the tetramer (χ^2^ = 9.6). Experimental radius of gyration is 25 Å.\
(D) In vitro APC ubiquitination assays with ^35^S-labeled *S. cerevisiae* securin and IVT-produced *Sc*Cdh1 and WT and mutant Acm1^CIR^. Acm1^CIR^-mediated inhibition is abolished by mutation of the DB3 (Acm1^CIR-mdb3^). In contrast to DB3 mutations, disruption of the NEN sequence (Acm1^CIR-mNEN^) does not impair Acm1^CIR^-mediated inhibition of APC/C^Cdh1^ ubiquitination of securin.](gr6){#fig6}

![Noncanonical D and KEN Boxes Interact with D and KEN Box Recognition Sites\
(A) Ubiquitination of *S. cerevisiae* securin, *S.cerevisiae* Spo13, *S. cerevisiae* Cin8p, and *X. laevis* Xkid relies on recognition of APC/C^Cdh1^ by the D box coreceptor. Ubiquitination is inhibited by a D box peptide (D) but not by a control peptide (C).\
(B) A conventional D box and noncanonical D box peptides (at 1 mM) reduce ubiquitination of ^35^S-labeled *S. cerevisiae* Clb2 with a disrupted KEN box (Clb2 mkb) to a level similar to that of Clb2 mdk with disrupted D and KEN boxes in the absence of peptide.\
(C) Xkid ubiquitination is dependent on the KEN box recognition site of Cdh1. Ubiquitination is abolished by disrupting either the D box receptor (mdr: *Hs*Cdh1^V203M^) or KEN box receptor (mkr: *Hs*Cdh1^Q401A/R445L^) of Cdh1. WT: wild-type *Hs*Cdh1. Human securin is used as a control.](gr7){#fig7}

###### 

Data Collection and Refinement Statistics

  Data Collection Statistics          
  ----------------------------------- --------------------------
  Beamline                            DLS IO4-1
  Wavelength (Å)                      0.9173
  Space group                         C2
  a (Å)                               198.43
  b (Å)                               188.14
  c (Å)                               93.44
  β (°)                               92.13
  Z (molecules per asymmetric unit)   8 × Cdh1 + 8 × Acm1
  Resolution (Å)                      93.38--2.90 (3.06--2.90)
  R~merge~                            0.102 (0.552)
  I/σ (I)                             8.0 (1.9)
  Observed reflections                206,547 (31,519)
  Unique reflections                  72,799 (10,826)
  Completeness (%)                    96.2 (98.0)
  Multiplicity                        2.8 (2.9)
                                      
  **Refinement Statistics**           
                                      
  Resolution limits (Å)               69.27--2.90
  R~work~                             0.2243
  R~free~                             0.2581
  Number of atoms                     21496
  Mean B-factors (Å^2^)               65.80
                                      
  **Rmsd from Ideal Values**          
                                      
  Bond length (Å)                     0.0135
  Bond angles (°)                     1.583
                                      
  **Ramachandran Plot Statistics**    
                                      
  Preferred (%)                       94.0
  Allowed (%)                         4.2
  Outliers (%)                        1.8

[^1]: These authors contributed equally to this work
